Ibex Medical Analytics
PrivateLast Round
Series C
Sep 6, 2023
Total Funding Raised
$117M
Momentum
Top 50%
of companies Caplight tracks
Company Overview
Ibex Medical Analytics operates in Healthcare & Life Sciences and is based in Tel Aviv. Its latest recorded funding round was a Series C round in September 2023.
Ibex Medical Analytics is a healthcare technology company that develops artificial intelligence-driven diagnostic solutions to enhance clinical decision-making and optimize pathology laboratory processes.
Sector
Healthcare & Life Sciences
Verticals
Medical AI, Medical Imaging, Healthcare Analytics, Precision Medicine
Business Model
B2B
Customer Profile
Subscription SaaS
AI Layer
Application
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Ibex Medical Analytics Comparables
Compare Ibex Medical Analytics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| MindPeak | 86% | |
| Visiopharm | 84% | |
| Tempus | 84% |
For institutional investors. Book with your work email.
Ibex Medical Analytics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series C | Sep 6, 2023 | ||||
| Debt | Nov 9, 2022 | ||||
| Series B | Mar 9, 2021 | ||||
| Series A | Mar 20, 2019 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
Ibex Medical Analytics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Kreos Capital | Debt |
| Kreos Capital | Debt |
| Sienna Investment Managers | Series C |
| Kamet Ventures | Series A, Seed |
| 83North | Series A, Series C, Series B |
| aMoon | Series C, Series B, Series A |
| Dell Technologies Capital | Series C, Series B, Series A |
For institutional investors. Book with your work email.
Market signals
Structured signals derived from secondary market and firmographic data.
- May 22, 2026
Added ByteDance, a technology and social media company, as a customer.
- Apr 9, 2026
Launched its next-generation AI pathology platform.
For institutional investors. Book with your work email.
Recent news
Latest coverage and updates
- is_developingOct 20, 2026
Ibex plans to develop the platform with Proscia in Israel and Pennsylvania to automate biomarker scoring and integrate it into digital pathology workflows.
- launchesSep 9, 2026
Ibex launches Ibex Breast Lymph Node in Massachusetts on Sep 9th '26, offering laboratories a unified workflow from primary biopsy and excision review to IHC pre-ordering and scoring across biopsies, resections and lymph nodes.
For institutional investors. Book with your work email.
Ibex Medical Analytics Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Ibex Medical Analytics's valuation, stock price, and market status.
Is Ibex Medical Analytics a public or private company?
Ibex Medical Analytics is a private company.
What is the current stock price of Ibex Medical Analytics?
Ibex Medical Analytics is a private company, so its shares have no public market price. Caplight tracks Ibex Medical Analytics's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Ibex Medical Analytics worth (valuation)?
Valuation information for Ibex Medical Analytics is not publicly available.
Can I buy Ibex Medical Analytics stock?
Ibex Medical Analytics shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Ibex Medical Analytics's last funding round?
Ibex Medical Analytics's most recent funding round was Series C on September 6, 2023.
Who are the main investors in Ibex Medical Analytics?
Key investors in Ibex Medical Analytics include Kreos Capital, Kreos Capital, Kamet Ventures, 83North, aMoon.
Will Ibex Medical Analytics IPO soon?
No public IPO plans have been announced for Ibex Medical Analytics.
How can I track Ibex Medical Analytics secondary market activity?
Caplight tracks bids, offers, and trades in Ibex Medical Analytics's shares on secondary markets.